suppression of in vitro and in vivo parameters of inflammatory synovitis by simvastatin抑制体外和体内参数辛伐他汀的炎性滑膜炎.pdfVIP

下载本文档

1
0
约 8页
2017-09-12 发布于上海
举报
版权申诉

suppression of in vitro and in vivo parameters of inflammatory synovitis by simvastatin抑制体外和体内参数辛伐他汀的炎性滑膜炎.pdf

1、本文档共8页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

suppression of in vitro and in vivo parameters of inflammatory synovitis by simvastatin抑制体外和体内参数辛伐他汀的炎性滑膜炎

Ishijima et al. Arthritis Research Therapy 2014, 16:R18 /content/16/1/R18 RESEARCH ARTICLE Open Access Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial 1* 2 3 4 5 6 Muneaki Ishijima , Toshitaka Nakamura , Katsuji Shimizu , Kunihiko Hayashi , Hiraku Kikuchi , Satoshi Soen , 7 8 9 10 4 1 1 Go Omori , Toshihiko Yamashita , Yuji Uchio , Junji Chiba , Yuki Ideno , Mitsuaki Kubota , Hisashi Kurosawa , Kazuo Kaneko1 and for the Research Group of Cartilage Metabolism Abstract Introduction: While many of the commonly used conservative treatments for knee osteoarthritis (OA) have been recognized to be effective, there is still insufficient evidence available. Among the pharmacological treatments for knee OA, oral non-steroidal anti-inflammatory drugs (NSAIDs) act rapidly and are recommended for the management of OA. However, frequent and serious adverse effects of NSAIDs have been recognized. Intra-articular injections of hyaluronic acid (IA-HA) for the treatment of knee OA have been shown to reduce pain and improve joint function. However, there has been no qualified direct comparison study of the efficacy and safety between IA-HA and NSAIDs for patients with knee OA. The aim of this study was to clarify the efficacy and safety of early-phase IA-HA in comparison to those of NSAIDs for patients with knee OA. Methods: This multicenter, randomized, open-label, parallel-group, non-inferiority comparison study with an oral NSA